Source: Reklaim
  • Reklaim (MYID) has announced a non-brokered private placement for gross proceeds of up to $1 million
  • The offering will consist of up to 28,571,428 units at $0.035 per unit
  • Net proceeds will be used for acquisition, sales growth, and general corporate purposes
  • The offering is expected to close on or around December 15, 2022
  • Reklaim offers a platform that allows consumers to protect and monetize their data
  • Reklaim Ltd. (MYID) opened trading at C$0.035

Reklaim (MYID) has announced a non-brokered private placement for gross proceeds of up to $1 million.

The offering will consist of up to 28,571,428 units at $0.035 per unit. Each unit will include one common share and one share purchase warrant. Each warrant will entitle the holder to purchase one additional common share for a period of 36 months following the closing of the offering.

Warrants are subject to an acceleration clause.

Net proceeds will be used for acquisition, sales growth, and general corporate purposes.

A finder’s fee will be payable on a portion of the offering.

Because the offering is being completed pursuant to the Listed Issuer Financing Exemption, the securities issued will not be subject to a hold period.

The offering is expected to close on or around December 15, 2022.  Reklaim offers a platform that allows consumers to protect and monetize their data.

Reklaim Ltd. (MYID) opened trading at C$0.035.


More From The Market Online
Neon lights winding around city roads.

Transportation technology stock secures second major contract in a week

Transpo tech stock Quarterhill (TSX:QTRH) just signed a contract to help improve road safety and foster the regulatory environment.
Sol Strategies CEO, Leah Wald

Solana-focused Sol Strategies attracts institutional capital

Global blockchain investor ParaFi Capital will allocate C$27.5 million into Solana-focused crypto operation Sol Strategies (CSE:HODL).
SurgiClear antimicrobial clear silicone adhesive dressing with chlorhexidine and silver

Covalon Technologies posts third profitable quarter in a row

Covalon Technologies (TSXV:COV), a healthcare technology stock, achieves net income profitability for the third straight quarter in Q4 2024.